De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures.

TitleDe Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures.
Publication TypeJournal Article
Year of Publication2018
AuthorsIto, Y, Carss, KJ, Duarte, ST, Hartley, T, Keren, B, Kurian, MA, Marey, I, Charles, P, Mendonça, C, Nava, C, Pfundt, R, Sanchis-Juan, A, van Bokhoven, H, van Essen, A, van Ravenswaaij-Arts, C, Boycott, KM, Kernohan, KD, Dyack, S, F Raymond, L
Corporate Authors,
JournalAm J Hum Genet
Volume103
Issue1
Pagination144-153
Date Published2018 Jul 05
ISSN1537-6605
Abstract

Next-generation sequencing has been invaluable in the elucidation of the genetic etiology of many subtypes of intellectual disability in recent years. Here, using exome sequencing and whole-genome sequencing, we identified three de novo truncating mutations in WAS protein family member 1 (WASF1) in five unrelated individuals with moderate to profound intellectual disability with autistic features and seizures. WASF1, also known as WAVE1, is part of the WAVE complex and acts as a mediator between Rac-GTPase and actin to induce actin polymerization. The three mutations connected by Matchmaker Exchange were c.1516C>T (p.Arg506Ter), which occurs in three unrelated individuals, c.1558C>T (p.Gln520Ter), and c.1482delinsGCCAGG (p.Ile494MetfsTer23). All three variants are predicted to partially or fully disrupt the C-terminal actin-binding WCA domain. Functional studies using fibroblast cells from two affected individuals with the c.1516C>T mutation showed a truncated WASF1 and a defect in actin remodeling. This study provides evidence that de novo heterozygous mutations in WASF1 cause a rare form of intellectual disability.

DOI10.1016/j.ajhg.2018.06.001
Alternate JournalAm. J. Hum. Genet.
Citation Key10.1016/j.ajhg.2018.06.001
PubMed ID29961568
PubMed Central IDPMC6037130